BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17086359)

  • 1. Neutrophil activator of matrix metalloproteinase-2 (NAM).
    Rollo EE; Hymowitz M; Schmidt CE; Montana S; Foda H; Zucker S
    Clin Exp Metastasis; 2006; 23(5-6):259-68. PubMed ID: 17086359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
    Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
    J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
    Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.
    Shamamian P; Schwartz JD; Pocock BJ; Monea S; Whiting D; Marcus SG; Mignatti P
    J Cell Physiol; 2001 Nov; 189(2):197-206. PubMed ID: 11598905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.
    Axelrad TW; Deo DD; Ottino P; Van Kirk J; Bazan NG; Bazan HE; Hunt JD
    FASEB J; 2004 Mar; 18(3):568-70. PubMed ID: 14715700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
    Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
    Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures.
    Ko K; Yazumi S; Yoshikawa K; Konda Y; Nakajima M; Chiba T; Takahashi R
    Int J Cancer; 2000 Jul; 87(2):165-71. PubMed ID: 10861469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
    Park JM; Kim A; Oh JH; Chung AS
    Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.
    Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM
    Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
    Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
    Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
    Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
    Park BC; Thapa D; Lee YS; Kwak MK; Lee ES; Choi HG; Yong CS; Kim JA
    Eur J Pharmacol; 2007 Jul; 567(3):193-7. PubMed ID: 17507007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S; Lee JG; Lovett DH; Sarkar R
    J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.